RITTER PHARMACEUTICALS
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. We are discovering a new frontier in human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into safe and effective applications that can have a meaningful impact on a patient’s health. Our pipeline of novel microbiome modulators ... selectively increase the growth of beneficial bacteria in the colonic ecosystem and create a meaningful impact on a patient’s health. Our first therapy, RP-G28, is currently under development for the treatment of lactose intolerance and has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease that affects over 1 billion people worldwide. RP-G28 has been studied in a Phase 2 clinical trial and is a first-in-class compound.
RITTER PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Diagnostics Medical Pharmaceutical Robotics
Founded:
2004-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.ritterpharma.com
Total Employee:
11+
Status:
Closed
Contact:
310-203-1000
Email Addresses:
[email protected]
Total Funding:
25.73 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email Stumbleupon Digg Del.icio.us
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Cotinga Pharmaceuticals
Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Aspire Capital Partners LLC
Aspire Capital Partners LLC investment in Post-IPO Equity - Ritter Pharmaceuticals
Javelin Venture Partners
Javelin Venture Partners investment in Venture Round - Ritter Pharmaceuticals
Javelin Venture Partners
Javelin Venture Partners investment in Venture Round - Ritter Pharmaceuticals
Official Site Inspections
http://www.ritterpharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
